APA (7th ed.) Citation

Stegmayr, C., Stoffels, G., Filß, C., Heinzel, A., Lohmann, P., Willuweit, A., . . . Langen, K. (2021). Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology. Nuclear medicine and biology, 92, 78-84. https://doi.org/10.1016/j.nucmedbio.2020.02.006

Chicago Style (17th ed.) Citation

Stegmayr, Carina, et al. "Current Trends in the Use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in Neurooncology." Nuclear Medicine and Biology 92 (2021): 78-84. https://doi.org/10.1016/j.nucmedbio.2020.02.006.

MLA (9th ed.) Citation

Stegmayr, Carina, et al. "Current Trends in the Use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in Neurooncology." Nuclear Medicine and Biology, vol. 92, 2021, pp. 78-84, https://doi.org/10.1016/j.nucmedbio.2020.02.006.